Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Absolute Resilience is a commercial endpoint protection platform tool by Absolute. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise security teams running mixed Windows and Mac fleets will get the most from Absolute Resilience because it actually fixes broken endpoints without waiting for tickets, using firmware-level recovery that survives OS corruption. The platform covers NIST RC.RP incident recovery and RS.MI mitigation through autonomous app repair and device rehydration from trusted images, meaning your team stops triaging and starts restoring at scale. Skip this if your priority is detection and threat hunting; Absolute is explicitly built for resilience and recovery, not visibility into active threats.
Tool that immunizes Windows systems against critical vulnerabilities
Endpoint resilience platform with self-healing apps and device recovery
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Absolute Resilience for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Absolute Resilience: Endpoint resilience platform with self-healing apps and device recovery. built by Absolute. Core capabilities include Application health monitoring across Windows and Mac applications, Autonomous application repair and reinstallation, Firmware-based endpoint recovery playbooks..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Absolute Resilience differentiates with Application health monitoring across Windows and Mac applications, Autonomous application repair and reinstallation, Firmware-based endpoint recovery playbooks.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Absolute Resilience is developed by Absolute. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and Absolute Resilience serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox